Abstract:368Basilar artery occlusion (Bao) is an infrequent form of acute ischemic stroke (aiS). this particular type of stroke occurs in approximately 1% of all-cause cases and is reported in approximately 8% of patients with symptomatic vertebrobasilar territory ischemia.1,2 Basilar artery occlusion symptoms are heterogeneous and may vary from mild neurological deficits consisting of visual, oculomotor, and behavioral abnormalities to a locked-in state or coma.3,4 however, severe and persistent ABSTRACT: Objective: t… Show more
“…These findings are consistent with our previous study in posterior-circulation strokes due to BA occlusion; higher NIHSS at the time of treatment, longer time to treatment and arterial hypertension were identified as independent negative predictors of favorable clinical outcome [17]. Likewise, the ASPECT score [18], older age, stroke severity and a history of diabetes mel litus were identified as negative predictors of good clinical outcome in posterior-circulation strokes [19].…”
Background: Endovascular ther apy (EVT) with stent retrievers has been shown to be superior and safe (in the anterior circulation) in comparison to intravenous thrombolysis (IVT) alone or no specifi c ther apy. We compared clinical outcome between patients undergo ing EVT admitted directly to comprehensive stroke centers (CSCs) and patients transfer red from primary stroke centers (PSCs) to a CSC. Materials and methods: Demographics, risk factors, and medical history of all consecutive EVT-treated stroke patients in col laborat ing stroke centers were col lected. Patients were divided into three groups: treatment with IVT in a PSC before transfer to a CSC for EVT; treatment with IVT directly in a CSC with subsequent EVT in the same center; no treatment with IVT before EVT. Neurological status us ing the National Institutes of Health Stroke Scale (NIHSS) on admis sion and at day 7 and self-suffi ciency us ing the modified Rankin Scale (mRS) at day 90 were as ses sed. Favorable clinical outcome was defi ned as an mRS score of 0-2. Fol low-up computed tomography or magnetic resonance imag ing was done to determine symp tomatic intracerebral hemor rhage (SICH). Results: A total of 568 patients (313 males; mean age, 66.1 ± 13.2 years) were registered from January 2006 to the end of July 2015. Patients in all three groups did not diff er in baseline characteristics except for the time to the start of EVT. The average delay of EVT start in patients transfer red from PSC to CSC was 45 min. Subgroups did not diff er signifi cantly in SICH prevalence (over all prevalence 5.5%) and favorable clinical outcome (over all 46.7%). Conclusion: The benefi t of direct transfer to a CSC merits further investigation. The present study showed that both approaches to stroke patient transport organization in the Czech Republic are comparably effi cient and safe. The authors declare they have no potential confl icts of interest concerning drugs, products, or services used in the study. Autoři deklarují, že v souvislosti s předmětem studie nemají žádné komerční zájmy. The Editorial Board declares that the manuscript met the ICMJE "uniform requirements" for biomedical papers. Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.
“…These findings are consistent with our previous study in posterior-circulation strokes due to BA occlusion; higher NIHSS at the time of treatment, longer time to treatment and arterial hypertension were identified as independent negative predictors of favorable clinical outcome [17]. Likewise, the ASPECT score [18], older age, stroke severity and a history of diabetes mel litus were identified as negative predictors of good clinical outcome in posterior-circulation strokes [19].…”
Background: Endovascular ther apy (EVT) with stent retrievers has been shown to be superior and safe (in the anterior circulation) in comparison to intravenous thrombolysis (IVT) alone or no specifi c ther apy. We compared clinical outcome between patients undergo ing EVT admitted directly to comprehensive stroke centers (CSCs) and patients transfer red from primary stroke centers (PSCs) to a CSC. Materials and methods: Demographics, risk factors, and medical history of all consecutive EVT-treated stroke patients in col laborat ing stroke centers were col lected. Patients were divided into three groups: treatment with IVT in a PSC before transfer to a CSC for EVT; treatment with IVT directly in a CSC with subsequent EVT in the same center; no treatment with IVT before EVT. Neurological status us ing the National Institutes of Health Stroke Scale (NIHSS) on admis sion and at day 7 and self-suffi ciency us ing the modified Rankin Scale (mRS) at day 90 were as ses sed. Favorable clinical outcome was defi ned as an mRS score of 0-2. Fol low-up computed tomography or magnetic resonance imag ing was done to determine symp tomatic intracerebral hemor rhage (SICH). Results: A total of 568 patients (313 males; mean age, 66.1 ± 13.2 years) were registered from January 2006 to the end of July 2015. Patients in all three groups did not diff er in baseline characteristics except for the time to the start of EVT. The average delay of EVT start in patients transfer red from PSC to CSC was 45 min. Subgroups did not diff er signifi cantly in SICH prevalence (over all prevalence 5.5%) and favorable clinical outcome (over all 46.7%). Conclusion: The benefi t of direct transfer to a CSC merits further investigation. The present study showed that both approaches to stroke patient transport organization in the Czech Republic are comparably effi cient and safe. The authors declare they have no potential confl icts of interest concerning drugs, products, or services used in the study. Autoři deklarují, že v souvislosti s předmětem studie nemají žádné komerční zájmy. The Editorial Board declares that the manuscript met the ICMJE "uniform requirements" for biomedical papers. Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.
“…To the best of our knowledge, this is the largest single-center series assessing the safety and clinical outcome of IVT for PCS. Most of the previously published studies evaluating the safety and efficacy of IVT for PCS had small sample sizes (range, 9–84 patients), they assessed ICH using a different definition of SICH, or they investigated acute basilar artery occlusion only (1,12–17).…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, this is the largest single-center series assessing the safety and clinical outcome of IVT for PCS. Most of the previously published studies evaluating the safety and efficacy of IVT for PCS had small sample sizes (range, 9-84 patients), they assessed ICH using a different definition of SICH, or they investigated acute basilar artery occlusion only (1,(12)(13)(14)(15)(16)(17). The rate of PCS among IVT-treated patients (12•8% in the present study) is lower than that reported in the non-IVT population (20-26%) (18,19), which may have several reasons: Initial symptoms such as vertigo or diplopia are misinterpreted or even neglected by the patients, prolonging time to treatment and possibly excluding patients from IVT therapy.…”
“…Thus, additional endovascular treatment should be started as soon as possible and not considered only as a rescue strategy (57, 58). Data from two small series on basilar artery occlusion patients (52, respectively 70 patients) reported better 90-day clinical outcomes in patients treated with bridging (59, 60).…”
Section: Ivt In Posterior Circulation Strokementioning
Background:
Intravenous thrombolysis (IVT) is a standard treatment for both anterior circulation ischemic stroke (ACIS) and posterior circulation ischemic stroke (PCIS). PCIS is a clinical syndrome associated with ischemia-related changes in the territory of the posterior circulation arteries. Embolism is the most common stroke mechanism in posterior circulation. PCIS represents 12–19% of all IVT-treated strokes.
Methods and Results:
We searched the PubMed database for assessments of intracerebral hemorrhage (ICH) and clinical outcome in PCIS patients treated with IVT. ICH occurs in 0–6.9% of posterior ischemic stroke depending on the definition of symptomatic ICH, and any ICH in 17–23.4% of posterior ischemic stroke. For patients with PCIS, 38–49% have a favorable outcome (mRS 0–1) after IVT. Better clinical outcomes occur more often in patients with PCIS than in those with ACIS. The mortality rate among PCIS patients treated with IVT ranges from 9 to 19%; it does not differ significantly between PCIS and ACIS.
Conclusions:
Up to date, no data about PCIS and IVT are available from RTCs. Based on limited results from retrospective clinical studies and case series, IVT is safer for use in PCIS than in ACIS. Patients with brainstem ischemia, vertebral artery occlusion, and absence of basilar or posterior cerebral artery occlusion could be considered for treatment with IVT even in borderline cases. Time to IVT in PCIS seems to be a less crucial factor than in ACIS. IVT for PCIS may be beneficial even after 4.5 h from symptom onset.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.